Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF).

Clinical trial NCT06159166 · RECRUITING

Trial details

NCT number: NCT06159166
Sponsor: Johns Hopkins University
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

NF1 Cutaneous Neurofibroma Monotherapy

Start date: 2024-02-12
Primary completion: 2027-11-15
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.